Compare Fubotv Inc (FUBO) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fubotv Inc vs Viatris Inc — how do they compare? Fubotv Inc trades at $9.4 (market cap $1.06B), while Viatris Inc trades at $16.23 (market cap $18.69B). The key difference: Viatris Inc is far larger — about 17.6× Fubotv Inc's market cap, and Viatris Inc pays a 2.95% dividend while Fubotv Inc pays none. Which is the better fit depends on your goals.
| FUBO | VTRS | |
|---|---|---|
Market Cap | $1.06B | $18.69B |
Sector | Technology | Health |
52-Week High | $54.72 | $17.86 |
52-Week Low | $8.09 | $9.49 |
Enterprise Value | $1.23B | $30.80B |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FUBO trades at $9.46, up 1.07% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q3 2026 revenue of $1.48 billion (Business Wire, 2026-08-05) and raised its full-year adjusted EBITDA target to $90–$100 million. Valuation ratios appear attractive with a P/S of 0.19 and P/B of 0.36, while recent earnings showed mixed results with two beats and one miss in the last four quarters.
The outlook is cautiously optimistic with analyst consensus pointing to significant upside to a $15.33 price target. Key opportunities include subscriber growth from live sports and advertising improvements, but risks persist from negative cash flows and high debt levels. Execution under new CEO Alisa Bowen and partnerships with Disney and NBCUniversal are critical for achieving profitability targets.
Viatris (VTRS) trades at $16.33, up 0.31% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q2 2026 EPS of $0.69, exceeding expectations, and revenue growth of 5% year-over-year. However, negative net income margins and a high P/E ratio of 236.2 highlight profitability challenges. Recent developments include FDA approval for Gwyn Lo contraceptive patch and ongoing divestitures to sharpen focus.
Outlook remains mixed: operational improvements and dividend payments offer stability, but persistent net losses and high debt pose risks. Analyst consensus leans Hold (61.54%), reflecting cautious optimism amid execution uncertainties. Investment appeal hinges on successful margin recovery and debt management in a competitive generic drug market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fubotv Inc
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.
Read more on FUBO →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
